In the Media

July 4, 2022

Pharma Tech Outlook: InMed Introduces THCV Into the Health and Wellness Industry

InMed’s THCV will bring ample opportunity to the health sector to scale up in the market.

Read full story via Pharma Tech Outlook.

Share this post

Latest Articles

How Could a Change in Legislation Affect the Cannabinoid Industry?

InMed’s VP, Sales & Marketing, Jerry P. Griffin, talks about how a change in legislation could impact the bioidentical cannabinoid manufacturing industry. In this interview,

May 16, 2023

BayMedica’s Bioidentical Rare Cannabinoids Fill a Market Need for Large Scale Batch-to-batch Consistency

InMed’s VP, Sales & Marketing, Jerry P. Griffin, talks about how the market for bioidentical rare cannabinoids has changed over the past year. Jerry contributes

May 8, 2023

The Dales Report: InMed’s Latest Milestones Explained

InMed CEO, Eric A. Adams, joins Shadd Dales of The Dales Report to speak about InMed’s latest milestones including the latest on the Phase 2

April 19, 2023